Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Accurate histologic diagnosis of gliomas is fundamental to proper patient management and to the interpretation of basic and clinical investigations. Diagnostic accuracy and reproducibility are compromised by the subjective histologic criteria currently used to classify and grade gliomas. METHODS: The histologic features of 4 sets of gliomas (a total of 244 cases) were reviewed independently by 4 neuropathologists to determine interobserver diagnostic concordance rates. Cases wherein diagnostic disagreements arose were reviewed jointly to identify and refine the histologic criteria that were adversely affecting diagnostic reproducibility. Using the criteria developed in the study, a set of 315 gliomas with known survival data was evaluated in order to validate the usefulness of the criteria. RESULTS: There was significant improvement in diagnostic concordance with each session (P = 0.02). For the first session, the concordance rates were as follows: all 4 reviewers, 52%; any 3 reviewers, 60%; 2 reviewers, 70%. For the fourth session, the respective rates were 69%, 75%, and 80%. Although features important in grading, particularly microvascular proliferation, were sometimes problematic, most disagreements related to the classification of tumors. Much of the improvement related to the refinement of criteria distinguishing diffuse astrocytomas from oligodendrogliomas/oligoastrocytomas and pilocytic astrocytomas. It was concluded that the presence of any typical oligodendroglioma was sufficient to remove a tumor from the astrocytoma category. CONCLUSIONS: The authors' data indicate that oligodendroglial tumors comprise up to 25% of gliomas, a significantly higher proportion than was previously recognized. The data also suggest that the wide range of survival times reported for patients with anaplastic astrocytoma may reflect "contamination" resulting from misdiagnosis, particularly of oligodendroglial tumors and pilocytic astrocytomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213
The neurofibromatosis type 1 gene encodes a protein related to GAP
Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90024-9 · Cited by 1,095
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899
Grading of astrocytomas: A simple and reproducible method
Daumas-Duport, C., Scheithauer, B., O'Fallon, J., & Kelly, P. (1988) · Cancer · doi:10.1002/1097-0142(19881115)62:10<2152::aid-cncr2820621015>3.0.co;2-t · Cited by 891
Application of artificial neural networks to clinical medicine
Baxt, W. G. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91804-3 · Cited by 677
Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications
Burger, P. C., Vogel, F. S., Green, S. B., & Strike, T. A. (1985) · Cancer · doi:10.1002/1097-0142(19850901)56:5<1106::aid-cncr2820560525>3.0.co;2-2 · Cited by 651
Long-Term Follow-up of von Recklinghausen Neurofibromatosis
Sørensen, S. A., Mulvihill, J. J., & Nielsen, A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604173141603 · Cited by 617
Research works printed but not linked: 66
- Potter, 1985, J Clin Oncol, 3, 353, 10.1200/JCO.1985.3.3.353 · DOI · Paper page
- Elias, 1989, Semin Oncol, 16, 305
- Kleinerman, 1995, Am J Clin Oncology, 18, 93, 10.1097/00000421-199504000-00001 · DOI · Paper page
- Kintzel, 1991, Clin Pharmacy, 10, 110
- Rosenberg, 1985, N Engl J Med, 313, 1485, 10.1056/NEJM198512053132327 · DOI · Paper page
- Smith, 1988, Science, 240, 1169, 10.1126/science.3131876 · DOI · Paper page
- Sznol, 1989, Cancer Treat Rev, 15, 29, 10.1016/0305-7372(89)90020-0 · DOI
- Espinoza-Delgadro, 1995, J Leukoc Biol, 57, 13, 10.1002/jlb.57.1.13 · DOI
- Grimm, 1991, J Cell Biochem, 45, 335, 10.1002/jcb.240450405 · doi:10.1002/jcb.240450405
- Rubin, 1993, Cancer Invest, 11, 460, 10.3109/07357909309018878 · DOI
- Kaplan, 1994, J Chromatogr B Biomed Appl, 662, 315, 10.1016/0378-4347(94)00212-6 · DOI
- Maas, 1993, Cancer Immunol Immunother, 36, 141, 10.1007/BF01741084 · DOI
- Marincola, 1995, J Clin Oncol, 13, 1110, 10.1200/JCO.1995.13.5.1110 · doi:10.1200/jco.1995.13.5.1110
- Anderson, 1992, Drug Devel Res, 27, 15, 10.1002/ddr.430270103 · DOI
- Guida, 1995, Cancer Biother, 10, 195, 10.1089/cbr.1995.10.195 · doi:10.1089/cbr.1995.10.195
- Menzel, 1993, Cancer Biother, 8, 199, 10.1089/cbr.1993.8.199 · doi:10.1089/cbr.1993.8.199
- Siegal, 1991, J Clin Oncol, 9, 694, 10.1200/JCO.1991.9.4.694 · DOI · Paper page
- Smith, 1993, Blood, 81, 1414, 10.1182/blood.V81.6.1414.1414 · DOI
- Anderson, 1994, Drug Disposition, 27, 19
- Helfand, 1994, Cancer Immunol Immunother, 39, 84, 10.1007/BF01525313 · doi:10.1007/bf01525313
- Waldrep, 1994, J Aerosol Med, 7, 135, 10.1089/jam.1994.7.135 · doi:10.1089/jam.1994.7.135
- Knight, 1988, J Infect Dis, 158, 443, 10.1093/infdis/158.2.443 · doi:10.1093/infdis/158.2.443
- Hodson, 1995, Am J Respir Crit Care Med, 151, s70, 10.1164/ajrccm/151.3_Pt_2.S70 · DOI
- Malone, 1993, Chest, 104, 114, 10.1378/chest.104.4.1114 · doi:10.1378/chest.104.4.1114
- Maasilta, 1991, Lancet, 337, 371, 10.1016/0140-6736(91)91009-J · doi:10.1016/0140-6736(91)91009-j
- Dowling, 1990, Surgery, 108, 198
- Gilbert, 1993, Transplantation, 56, 974, 10.1097/00007890-199310000-00037 · DOI
- New approaches in aerosol drug delivery for the treatment of asthma. In: editor. Allergy and allergic disease. London: Blackwell Scientific, 1995.
- Newman, 1983, Thorax, 38, 881, 10.1136/thx.38.12.881 · doi:10.1136/thx.38.12.881
- Huland, 1992, J Urol, 147, 344, 10.1016/S0022-5347(17)37233-6 · doi:10.1016/s0022-5347(17)37233-6
- Huland, 1994, J Cancer Res Clin Oncol, 120, 221, 10.1007/BF01372560 · doi:10.1007/bf01372560
- Khanna, 1994, Proc Am Assoc Cancer Res, 35, 414
- Zhang, 1994, Proc Am Assoc Cancer Res, 35, 519
- Juliano, 1980, J Pharmacol Exp Ther, 214, 381
- Ostro, 1989, Am J Hosp Pharm, 46, 1576
- Anderson, 1994, Cytokines, 6, 1, 10.1016/1043-4666(94)90014-0 · DOI
- Kedar, 1994, J Immunother, 16, 47, 10.1097/00002371-199407000-00005 · DOI
- Bergers, 1993, Pharmacol Res, 10, 1715, 10.1023/A:1018913912580 · DOI
- Loeffler, 1990, Cancer Res, 50, 1853
- Niven, 1991, Pharmacol Res, 8, 217, 10.1023/A:1015896121377 · doi:10.1023/a:1015896121377
- Martin, 1990, J Lipid Res, 1, 407
- Schreier, 1993, J Control Release, 24, 209, 10.1016/0168-3659(93)90180-D · DOI
- Khanna, 1996, Clin Cancer Res, 4, 719
- Anderson, 1990, Cancer Res, 50, 1853
- Moore, 1992, Tissue Antigens, 40, 75, 10.1111/j.1399-0039.1992.tb01963.x · doi:10.1111/j.1399-0039.1992.tb01963.x
- Anderson, 1989, J Immunol, 142, 1383, 10.4049/jimmunol.142.4.1383 · DOI
- Wee, 1981, Hum Immunol, 3, 45, 10.1016/0198-8859(81)90042-2 · doi:10.1016/0198-8859(81)90042-2
- Gong, 1994, Leukemia, 8, 652
- editor. TNM classification of tumors in domestic animals. 1st edition. Geneva: World Health Organization, 1980.
- Ogilvie, 1993, J Am Vet Med Assoc, 202, 304, 10.2460/javma.1993.202.02.304 · DOI
- Withrow, 1991, Clin Orthop, 270, 159, 10.1097/00003086-199109000-00023 · DOI · Paper page
- Brodey, 1977, J Am Vet Med Assoc, 168, 1032
- Spodnick, 1992, J Am Vet Med Assoc, 200, 995, 10.2460/javma.1992.200.07.995 · DOI · Paper page
- Powers, 1993, Cancer, 71, 2484, 10.1002/1097-0142(19930415)71:8<2484::AID-CNCR2820710810>3.0.CO;2-D · DOI · Paper page
- Shapiro, 1988, J Am Vet Med Assoc, 192, 507
- MacEwen, 1989, J Natl Cancer Inst, 81, 935, 10.1093/jnci/81.12.935 · DOI · Paper page
- Kurzman, 1995, Clin Cancer Res, 1, 1595
- Foon, 1989, Cancer Res, 49, 1621
- Lorenz, 1996, Clin Cancer Res, 2, 1115
- Fabian, 1994, Leukemia, 8, 1379
- Milne, 1995, Int Arch Allergy Immunol, 108, 60, 10.1159/000237119 · doi:10.1159/000237119
- Rivoltini, 1993, Int J Cancer, 54, 8, 10.1002/ijc.2910540103 · DOI
- Ishimitsu, 1993, Surgery, 113, 192
- Sencer, 1991, Eur Cytokine Netw, 2, 311
- Kilbourn, 1994, J Appl Physiol, 76, 1130, 10.1152/jappl.1994.76.3.1130 · doi:10.1152/jappl.1994.76.3.1130
- Knapp, 1995, Gene, 159, 281, 10.1016/0378-1119(95)00078-K · DOI
Cited by
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148
van den Bent, M. J., Brandes, A. A., Taphoorn, M. J. B., Kros, J. M., Kouwenhoven, M. C. M., Delattre, J.-Y., Bernsen, H. J. J. A., Frenay, M., Tijssen, C. C., Grisold, W., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2229 · Cited by 1,226
Primary brain tumours in adults
Ricard, D., Idbaih, A., Ducray, F., Lahutte, M., Hoang-Xuan, K., & Delattre, J.-Y. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61346-9 · Cited by 1,201
Hartmann, C., Meyer, J., Balss, J., Capper, D., Mueller, W., Christians, A., Felsberg, J., Wolter, M., Mawrin, C., Wick, W., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0561-9 · Cited by 1,163
Applications of Machine Learning in Cancer Prediction and Prognosis
Cruz, J. A., & Wishart, D. S. (2006) · Cancer Informatics · doi:10.1177/117693510600200030 · Cited by 1,100
Ahmed, Z., Mohamed, K., Zeeshan, S., & Dong, X. (2020) · Database · doi:10.1093/database/baaa010 · Cited by 1,035
van den Bent, M., Afra, D., de Witte, O., Hassel, M. B., Schraub, S., Hoang-Xuan, K., Malmström, P.-O., Collette, L., Piérart, M., Mirimanoff, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67070-5 · Cited by 1,035
Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma
Pignatti, F., van den Bent, M., Curran, D., Debruyne, C., Sylvester, R., Therasse, P., Áfra, D., Cornu, P., Bolla, M., Vecht, C., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.121 · Cited by 955
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
Fallon, M., Giusti, R., Aielli, F., Hoskin, P., Rolke, R., Sharma, M., & Ripamonti, C. I. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy152 · Cited by 954
Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium
Bondy, M. L., Scheurer, M. E., Malmer, B., Barnholtz-Sloan, J. S., Davis, F. G., Il'yasova, D., Kruchko, C., McCarthy, B. J., Rajaraman, P., Schwartzbaum, J. A., et al. (2008) · Cancer · doi:10.1002/cncr.23741 · Cited by 932
Glioma Subclassifications and Their Clinical Significance
Chen, R., Smith-Cohn, M., Cohen, A. L., & Colman, H. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0519-x · Cited by 812
Primary brain tumours in adults
Behin, A., Hoang-Xuan, K., Carpentier, A. F., & Delattre, J.-Y. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12328-8 · Cited by 754
van den Bent, M. J., Carpentier, A. F., Brandes, A. A., Sanson, M., Taphoorn, M. J. B., Bernsen, H. J. J. A., Frenay, M., Tijssen, C. C., Grisold, W., Sipos, L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6078 · Cited by 748
Gene Expression Profiling of Gliomas Strongly Predicts Survival
Freije, W. A., Castro-Vargas, F. E., Fang, Z., Horvath, S., Cloughesy, T., Liau, L. M., Mischel, P. S., & Nelson, S. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0452 · Cited by 744
Translation of new cancer treatments from pet dogs to humans
Paoloni, M., & Khanna, C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2273 · Cited by 668
Self-citationThe diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Laws, E. R., Parney, I. F., Huang, W., Anderson, F., Morris, A. M., Asher, A., Lillehei, K. O., Bernstein, M., Brem, H., Sloan, A., et al. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.99.3.0467 · Cited by 670
van den Bent, M. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0725-7 · Cited by 577
Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma
Bettegowda, C., Agrawal, N., Jiao, Y., Sausen, M., Wood, L. D., Hruban, R. H., Rodriguez, F. J., Cahill, D. P., McLendon, R., Riggins, G., et al. (2011) · Science · doi:10.1126/science.1210557 · Cited by 553
Law, M., Young, R. J., Babb, J. S., Peccerelli, N., Chheang, S., Gruber, M. L., Miller, D. C., Golfinos, J. G., Zagzag, D., & Johnson, G. (2008) · Radiology · doi:10.1148/radiol.2472070898 · Cited by 534
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
Soffietti, R., Baumert, B. G., Bello, L., Von Deimling, A., Duffau, H., Frénay, M., Grisold, W., Grant, R., Graus, F., Hoang‐Xuan, K., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03151.x · Cited by 505
Nanomedicine in pulmonary delivery
Mansour, H., Haemosu, & Wu, X. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4937 · Cited by 485
Reuss, D. E., Sahm, F., Schrimpf, D., Wiestler, B., Capper, D., Koelsche, C., Schweizer, L., Korshunov, A., Jones, D. T. W., Hovestadt, V., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1370-3 · Cited by 449
Patel, S. H., Poisson, L. M., Brat, D. J., Zhou, Y., Cooper, L., Snuderl, M., Thomas, C., Franceschi, A. M., Griffith, B., Flanders, A. E., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0560 · Cited by 424
Changing Paradigms—An Update on the Multidisciplinary Management of Malignant Glioma
Stupp, R., Hegi, M. E., van den Bent, M. J., Mason, W. P., Weller, M., Mirimanoff, R. O., Cairncross, J. G., & on behalf of the European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups and the National Cancer Institute of Canada Clinical Trials Group (2006) · The Oncologist · doi:10.1634/theoncologist.11-2-165 · Cited by 373
Hoang-Xuan, K., Capelle, L., Kujas, M., Taillibert, S., Duffau, H., Lejeune, J., Polivka, M., Crinière, E., Marie, Y., Mokhtari, K., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.169 · Cited by 356
Olar, A., Wani, K. M., Alfaro-Munoz, K. D., Heathcock, L. E., van Thuijl, H. F., Gilbert, M. R., Armstrong, T. S., Sulman, E. P., Cahill, D. P., Vera-Bolanos, E., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1398-z · Cited by 354
Altered adenosine-to-inosine RNA editing in human cancer
Paz, N., Levanon, E. Y., Amariglio, N., Heimberger, A. B., Ram, Z., Constantini, S., Barbash, Z. S., Adamsky, K., Safran, M., Hirschberg, A., et al. (2007) · Genome Research · doi:10.1101/gr.6493107 · Cited by 346
Perfusion MRI: The Five Most Frequently Asked Clinical Questions
Essig, M., Nguyen, T. B., Shiroishi, M. S., Saake, M., Provenzale, J. M., Enterline, D. S., Anzalone, N., Dörfler, A., Rovira, À., Wintermark, M., et al. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.9544 · Cited by 344
Sun, D., Wang, M., & Li, A. (2019) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2806438 · Cited by 338
Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression
Brassart-Pasco, S., Brézillon, S., Brassart, B., Ramont, L., Oudart, J.-B., & Monboisse, J. C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00397 · Cited by 335
Van Brocklyn, J. R., Jackson, C. A., Pearl, D. K., Kotur, M. S., Snyder, P. J., & Prior, T. W. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000175329.59092.2c · Cited by 330
Ellison, D. W., Kocak, M., Figarella-Branger, D., Felice, G., Catherine, G., Pietsch, T., Frappaz, D., Massimino, M., Grill, J., Boyett, J. M., et al. (2011) · Journal of Negative Results in BioMedicine · doi:10.1186/1477-5751-10-7 · Cited by 308
Louis, D. N., Holland, E. C., & Cairncross, J. G. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61750-6 · Cited by 298
Histologic classification of gliomas
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802997-8.00005-0 · Cited by 297
Mangal, S., Gao, W., Li, T., & Zhou, Q. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.34 · Cited by 288
Liposomal Drug Formulations: Rationale for Development and What We Can Expect for the Future
Allen, T. M. (1998) · Drugs · doi:10.2165/00003495-199856050-00001 · Cited by 283
Isocitrate dehydrogenase mutations in gliomas
Waitkus, M. S., Diplas, B. H., & Yan, H. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov136 · Cited by 282
Therapy for Osteosarcoma: Where Do We Go From Here?
Chou, A. J., Geller, D. S., & Gorlick, R. (2008) · Pediatric Drugs · doi:10.2165/00148581-200810050-00005 · Cited by 274
Sahm, F., Reuss, D., Koelsche, C., Capper, D., Schittenhelm, J., Heim, S., Jones, D. T. W., Pfister, S. M., Herold-Mende, C., Wick, W., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1326-7 · Cited by 272
Canine Osteosarcoma: A Naturally Occurring Disease to Inform Pediatric Oncology
Fenger, J. M., London, C. A., & Kisseberth, W. C. (2014) · ILAR Journal · doi:10.1093/ilar/ilu009 · Cited by 248
Molecular Classification of Low-Grade Diffuse Gliomas
Kim, Y.-H., Nobusawa, S., Mittelbronn, M., Paulus, W., Brokinkel, B., Keyvani, K., Sure, U., Wrede, K., Nakazato, Y., Tanaka, Y., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100680 · Cited by 240
Unsupervised Analysis of Transcriptomic Profiles Reveals Six Glioma Subtypes
Li, A., Walling, J., Ahn, S., Kotliarov, Y., Su, Q., Quezado, M., Oberholtzer, J. C., Park, J., Zenklusen, J. C., & Fine, H. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2100 · Cited by 220
“The need for an objective, biological-based classification of gliomas is exemplified by the high rate of divergent diagnoses, the inexact prognostic capabilities, and poor therapeutic predictive properties of the current histopathologic classification schemes (10).”
BackgroundOligodendrogliomas: Reproducibility and prognostic value of histologic diagnosis and grading
Giannini, C., Scheithauer, B. W., Weaver, A. L., Burger, P. C., Kros, J. M., Mork, S., Graeber, M. B., Bauserman, S., Buckner, J. C., Burton, J., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.3.248 · Cited by 219
Self-citationBarker, J., Hoogi, A., Depeursinge, A., & Rubin, D. L. (2016) · Medical Image Analysis · doi:10.1016/j.media.2015.12.002 · Cited by 216
“However, these features are not always clear, and they can be difficult to find and recognize in whole slide images, likely accounting for the high inter-reader variability observed between pathologists (Coons et al., 1997).”
BackgroundNie, D., Lu, J., Zhang, H., Adeli, E., Wang, J., Yu, Z., Liu, L., Wang, Q., Wu, J., & Shen, D. (2019) · Scientific Reports · doi:10.1038/s41598-018-37387-9 · Cited by 213
Brain tumor characterization using the soft computing technique of fuzzy cognitive maps
Papageorgiou, E. I., Spyridonos, P. P., Glotsos, D. T., Stylios, C. D., Ravazoula, P., Nikiforidis, G. N., & Groumpos, P. P. (2008) · Applied Soft Computing · doi:10.1016/j.asoc.2007.06.006 · Cited by 207
The epidemiology of glioma in adults: a "state of the science" review
Morgan, L. L. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou358 · Cited by 194
Shoshan, Y., Nishiyama, A., Chang, A., Mörk, S., Barnett, G. H., Cowell, J. K., Trapp, B. D., & Staugaitis, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10361 · Cited by 190
The Applications of Genetic Algorithms in Medicine
Ghaheri, A., Shoar, S., Naderan, M., & Hoseini, S. S. (2015) · Oman Medical Journal · doi:10.5001/omj.2015.82 · Cited by 186
Two types of chromosome 1p losses with opposite significance in gliomas
Idbaih, A., Marie, Y., Pierron, G., Brennetot, C., Hoang-Xuan, K., Kujas, M., Mokhtari, K., Sanson, M., Lejeune, J., Aurias, A., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20607 · Cited by 167
Sasaki, H., Zlatescu, M. C., Betensky, R. A., Ino, Y., Cairncross, J. G., & Louis, D. N. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61702-6 · Cited by 159
Liposomal delivery of proteins and peptides
Swaminathan, J., & Ehrhardt, C. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.735658 · Cited by 135
Cimino, P. J., Zager, M., McFerrin, L., Wirsching, H.-G., Bolouri, H., Hentschel, B., von Deimling, A., Jones, D., Reifenberger, G., Weller, M., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0443-7 · Cited by 126
Calcification in breast lesions: pathologists’ perspective
Tse, G. M., Tan, P.-H., Pang, A. L. M., Tang, A. P. Y., & Cheung, H. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.046201 · Cited by 95
Metal peroxides for cancer treatment
He, J., Fu, L.-H., Qi, C., Lin, J., & Huang, P. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.01.026 · Cited by 93
Fan, T. M., Roberts, R. D., & Lizardo, M. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00013 · Cited by 90
Biomarkers in Lung Cancer: From Early Detection to Novel Therapeutics and Decision Making
Scott, A., & Salgia, R. (2008) · Biomarkers in Medicine · doi:10.2217/17520363.2.6.577 · Cited by 59
Canine Cancer: Strategies in Experimental Therapeutics
Thamm, D. H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01257 · Cited by 38
Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs
Brady, R. V., & Thamm, D. H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1176807 · Cited by 35
Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets
Ghimenti, C., Fiano, V., Chiadò-Piat, L., Chiò, A., Cavalla, P., & Schiffer, D. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1022127302008 · Cited by 21
A Prospective Pilot Clinical Trial of “The Work” Meditation Technique for Survivors of Breast Cancer
Lev-ari, S., Zilcha-Mano, S., Rivo, L., Geva, R., & Ron, I. (2013) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2013.07.003 · Cited by 19
Metadata
- Authors
- Khanna, C., Anderson, P. M., Hasz, D. E., Katsanis, E., Neville, M., & Klausner, J. S.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 1997-04-01
- Volume
- 79
- Issue
- 7
- Pages
- 1409-1421
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- DOI
- 10.1002/(sici)1097-0142(19970401)79:7
- OpenAlex
- W2046796218
- Cited by
- 561
- References
- 25
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 6727 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.